Generics Industry Research

Find market research and analysis on the generics industry. Our industry research reports give you a comprehensive look into market conditions and forecasts, in addition to product trends and analyses. Industry overviews, market share and growth, sales statistics and projections, and company profiles are also featured.

	Title	Published	Price
1	Asia Pacific Pharma Sector Analysis	Nov 2009	$1,200.00
	The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region more... Published by: RNCOS
2	Generic Pharmaceuticals Industry Report	Nov 2009	$1,500.00
	The Global Generic Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth more... Published by: Plimsoll Publishing Ltd.
3	Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis	Nov 2009	$175.00
	Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. more... Published by: Aruvian's R'search | Search inside this report
4	Antipsychotics Market Forecast	Oct 2009	$15,200.00
	Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is more... Published by: Datamonitor
5	Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion	Oct 2009	$15,200.00
	Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is more... Published by: Datamonitor
6	Generics: Global Industry Guide	Oct 2009	$1,495.00
	Datamonitor's Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the Generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive more... Published by: Datamonitor | Search inside this report
7	Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential	Oct 2009	$15,200.00
	Introduction In 2008, seven major market sales of anticonvulsants reached $13.6 billion, making it one of the largest therapeutic drug classes in the Pharmaceutical sector. However, generic incursion of second generation anticonvulsants will continue to increase more... Published by: Datamonitor
8	Partnering in the Global Generics Industry 2008: A Guide to Companies	Oct 2009	$1,130.00
	Partnering is increasingly the choice for securing market share and business growth... ... Teva’s recent acquisition of Barr Pharmaceuticals may be the latest headline grabbing deal, but industry and commerce alike must have a complete more... Published by: Espicom Healthcare Intelligence | Search inside this report
9	Cardiovascular Outlook: Pharmaceutical, Medical Device, New Technologies - Past, Present, and Future	Oct 2009	$535.00
	Cardiovascular disease is the leading cause of death in the United States, affecting an estimated 80.7 million American adults, with estimated treatment costs of more than $313.8 billion annually. This report contains qualitative analysis of more... Published by: Canon Communications, LLC
10	China Hospital Drug Utilization Volume Executive Summary 2nd Edition 2009	Oct 2009	$4,400.00
	The total Chinese pharmaceutical market had reached RMB 828.36 billion (US$ 120.84 billion, at an exchange rate of US $1 = RMB 6.83) with an annual growth rate (AGR) of 26.50% in 2008. The growth more... Published by: Draco Healthcare Consulting LLC
11	E7: The Outlook for Pharmaceuticals to 2012	Sep 2009	$3,790.00
	E7: The Outlook for Pharmaceuticals to 2012 is a new collection of management reports from Espicom Business Intelligence. Each report provides an individual and highly-detailed analysis of each market, looking at the key regulatory, more... Published by: Espicom Healthcare Intelligence
12	The Outlook for Pharmaceuticals in Western Europe	Sep 2009	$3,790.00
	The countries of Western Europe represent a total market of over 365 million people and a combined GDP of US$14.4 trillion in 2007. The 11 main Western European markets for pharmaceuticals are wealthy and more... Published by: Espicom Healthcare Intelligence
13	The Outlook for Pharmaceuticals in South East Asia	Sep 2009	$3,790.00
	The eight Asian countries covered in this service represented a total market of 588 million people and a combined GDP of US$2.8 trillion in 2008 Business opportunities in Asian pharmaceutical markets are very different more... Published by: Espicom Healthcare Intelligence
14	The Outlook for Pharmaceuticals in Northern Europe	Sep 2009	$3,790.00
	The Outlook for Pharmaceutical Markets in Northern Europe is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, more... Published by: Espicom Healthcare Intelligence
15	The Outlook for Pharmaceuticals in Latin America	Sep 2009	$3,790.00
	The pharmaceutical markets in Latin America are worth US$50 billion - and growing fast! The eight Latin American markets covered by Espicom Business Intelligence represent a market of 474 million people with a GDP more... Published by: Espicom Healthcare Intelligence
16	The Pharmaceutical Market: Peru	Sep 2009	$1,130.00
	Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section more... Published by: Espicom Healthcare Intelligence | Search inside this report
17	The Pharmaceutical Market: India	Sep 2009	$1,130.00
	Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section more... Published by: Espicom Healthcare Intelligence
18	The Pharmaceutical Market: Chile	Sep 2009	$1,130.00
	Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section more... Published by: Espicom Healthcare Intelligence
19	Pharmaceutical Pricing and Reimbursement in India	Sep 2009	$2,250.00
	Introduction Faced with a dramatic slowdown in sales in mature pharmaceutical markets, multinational pharmaceutical companies are looking to substantially increase their sales in India and other emerging markets. The Indian market is growing by more more... Published by: Decision Resources
20	The Global Generic Pharmaceuticals Industry Report	Sep 2009	$1,500.00
	The Global Generic Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth more... Published by: Plimsoll Publishing Ltd.
21	Rethinking Pharmaceutical R&D: Will New Strategies Yield a Pipeline Payoff?	Sep 2009	$2,250.00
	Introduction Can radical changes to the structures and strategies of pharmaceutical R&D operations—such as creating more entrepreneurial environments modeled upon biotech companies—increase their productivity? Many major companies are reorganizing the research branches of their businesses more... Published by: Decision Resources
22	Generics in the United States	Sep 2009	$250.00
	Datamonitor's Generics in the United States industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis more... Published by: Datamonitor | Search inside this report
23	Generics in the United Kingdom	Sep 2009	$250.00
	Datamonitor's Generics in the United Kingdom industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis more... Published by: Datamonitor | Search inside this report
24	Generics in the Netherlands	Sep 2009	$250.00
	Datamonitor's Generics in the Netherlands industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of more... Published by: Datamonitor | Search inside this report
25	Generics in Spain	Sep 2009	$250.00
	Datamonitor's Generics in Spain industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the more... Published by: Datamonitor | Search inside this report
	Title	Published	Price